185 related articles for article (PubMed ID: 28716762)
1. Selective Window Application of Gentamicin+ Dexamethasone in Meniere's Disease.
Ardıç FN; Tümkaya F; Aykal K; Çabuk B
J Int Adv Otol; 2017 Aug; 13(2):243-246. PubMed ID: 28716762
[TBL] [Abstract][Full Text] [Related]
2. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
Wang XY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059
[No Abstract] [Full Text] [Related]
3. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
4. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
6. Middle ear gentamicin-soaked pledgets in the treatment of Ménière's disease.
MacKeith SA; Whiteside OJ; Mawby T; Bottrill ID
Otol Neurotol; 2014 Feb; 35(2):305-9. PubMed ID: 24448291
[TBL] [Abstract][Full Text] [Related]
7. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
10. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
Rah YC; Han JJ; Park J; Choi BY; Koo JW
Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
12. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
13. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
Crane BT; Minor LB; Della Santina CC; Carey JP
Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic gentamicin therapy for intractable Ménière's disease.
De Beer L; Stokroos R; Kingma H
Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
[TBL] [Abstract][Full Text] [Related]
15. Is low-dose intratympanic gentamicin an effective treatment for Ménière's disease: the Birmingham experience.
Watson GJ; Nelson C; Irving RM
J Laryngol Otol; 2015 Oct; 129(10):970-3. PubMed ID: 26328875
[TBL] [Abstract][Full Text] [Related]
16. Direct round window membrane application of gentamicin in the treatment of Meniere's disease.
Silverstein H; Arruda J; Rosenberg SI; Deems D; Hester TO
Otolaryngol Head Neck Surg; 1999 May; 120(5):649-55. PubMed ID: 10229588
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
18. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
20. Effect of intratympanically administered gentamicin on hearing and tinnitus in Menière's disease.
Kaasinen S; Pyykkö I; Ishizaki H; Aalto H
Acta Otolaryngol Suppl; 1995; 520 Pt 1():184-5. PubMed ID: 8749114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
